DEA proposes special registrations for telehealth prescribing

DEA proposes special registrations for telehealth prescribing 
TechTarget - xtelligent Virtual Healthcare; by Anuja Vaidya; 1/15/25  
The DEA is set to publish a proposal for a special registrations framework that would allow certain healthcare practitioners to prescribe controlled substances via telehealth without performing an in-person exam first. The unpublished proposal made available on the Federal Register details the special registrations framework, which includes three types of registrations:

1. A telemedicine prescribing registration would authorize qualified clinician practitioners, including registered physicians and midlevel practitioners, to prescribe Schedule III-V controlled substances via telehealth.
2. An advanced telemedicine prescribing registration would allow specialized clinician practitioners, such as psychiatrists and hospice care physicians, to prescribe Schedule II-V controlled substances via telehealth.
3. A telemedicine platform registration would authorize covered online telehealth platforms to dispense Schedule II-V controlled substances.